journal article·2022-09-01Open access

Preparation of graphene oxide membrane-daptomycin/epidermal growth factor dressing and its effect on wound healing

Daijun Zhou, Peng tian, Dong Li, Jianjun Li, Tao Zhang

Materials Research Express· Volume 9· Issue 9

Abstract

Abstract Herein, a series of environmentally friendly dressings were specially fabricated from graphene oxide (GO) membrane (a high quality substrate with antibacterial function) and Daptomycin (antibacterial function)/Epidermal growth factor (EGF, wound healing function) for the purpose of antibacterial applications. A performance comparison was designed by employing four dressing samples, including the neat GO membrane (Group A), GO membrane-Daptomycin (Group B), GO membrane-EGF (Group C), and GO membrane-Daptomycin/EGF (Group D). The results analyzed using Fourier transform infrared spectroscopy suggested that Daptomycin and EGF might be adhered to the GO membrane. The contact angle test showed that the hydrophilicity of material gradually increased from Group A to Group D. Groups B and D displayed similar in vitro antibacterial activities, better than those of Groups A and C (their antibacterial performances were similar to each other); all the four experimental groups outperformed the control group (P > 0.05). On the other hand, Groups C and D could promote the proliferation effectively within 1–7 days (P < 0.05), and they also showed similar activities in the cell migration, which were higher than those of Groups A and B (close to each other); all the experimental groups outdid the control group (P < 0.05). Moreover, by monitoring the expression levels of PCNA and CD31 , samples from Group D could promote both angiogenesis and cell reproduction when covering the skin defects (P < 0.05). At the seventh days after the injury, the control and experimental groups of A, B, C, and D displayed healing rates of 40.6%, 53.0%, 66.8%, 60.1%, and 68.3%, respectively. Based on a successful fabrication of GO membrane-Daptomycin/EGF dressings, antibacterial effects as well as growth-promoting performance were well realized by samples in Group D. This is benifitial for the wound healing to a great extent.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Wound Healing and Treatments · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF10.1128/AAC.00202-07 ↗
2. Development of daptomycin for gram-positive infections10.1093/jac/46.4.523 ↗
3. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant
4. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients10.1016/j.jinf.2006.11.007 ↗
5. A current perspective on daptomycin for the clinical microbiologist10.1128/CMR.00030-13 ↗
6. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy10.1128/AAC.49.4.1664-1665.2005 ↗
7. Antibacterial activity of graphene-based materials10.1039/C6TB01647B ↗
8. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in pseudomonas aeruginosa10.2147/IJN.S37397 ↗
9. Mechanisms of the antimicrobial activities of graphene materials10.1021/jacs.5b11411 ↗
10. Facile preparation and characterization of poly(vinyl alcohol)/chitosan/graphene oxide biocomposite nanofibers10.1016/j.jiec.2014.02.009 ↗
11. Colloidal stability of graphene oxide: aggregation in two dimensions10.1021/acs.langmuir.6b01012 ↗
12. The controversial antibacterial activity of graphene-based materials10.1016/j.carbon.2016.04.046 ↗
13. The graphene oxide contradictory effects against human pathogens10.1088/1361-6528/aa6150 ↗
14. Facile synthesis of monodispersed silver nanoparticles on graphene oxide sheets with enhanced antibacterial activity10.1039/c1nj20076c ↗
15. Eco-friendly decoration of graphene oxide with biogenic silver nanoparticles: antibacterial and antibiofilm activity10.1007/s11051-013-2110-7 ↗
16. Graphene oxide: a nonspecific enhancer of cellular growth10.1021/nn202699t ↗
17. Simultaneous reduction and surface functionalization of graphene oxide by mussel‐inspired chemistry10.1002/adfm.201001692 ↗
18. Removal of Cu(II) and fulvic acid by graphene oxide nanosheets decorated with Fe3O4 nanoparticles10.1021/am301358b ↗
19. Facile synthesis of silver@graphene oxide nanocomposites and their enhanced antibacterial properties10.1039/c0jm03376f ↗
20. Anti-adhesion and antibacterial activity of silver nanoparticles supported on graphene oxide sheets10.1016/j.colsurfb.2013.08.006 ↗
21. Mechanisms of silver nanoparticle-induced toxicity and important role of autophagy10.1080/17435390.2016.1189614 ↗
22. The disinfection performance and mechanisms of Ag/Daptomycin nanoparticles supported with montmorillonite clay10.1016/j.jhazmat.2016.05.089 ↗
23. Binding of copper to Daptomycin: Spectroscopic,isothermal titration calorimetry and molecular docking studies10.1016/j.saa.2016.04.008 ↗
24. Daptomycin as a recognition element for monitoring of bacterial population10.1016/j.talanta.2015.08.056 ↗
25. Pectin/Daptomycin bilayers layer-by-layer deposited cellulose nanofibrous mats for antibacterial application10.1016/j.carbpol.2014.10.064 ↗
26. Using complex coacervation for Daptomycin encapsulation by spray-drying10.1016/j.jfoodeng.2016.03.016 ↗
27. Gelatin/carboxymethyl cellulose mucoadhesive films with Daptomycin:Development and characterization10.1016/j.carbpol.2016.04.006 ↗
28. Dual growth factor releasing multifunctional nanofibers for wound healing10.1016/j.actbio.2013.07.030 ↗
29. Perspective article: growth factors and cytokines in wound healing10.1111/j.1524-475X.2008.00410.x ↗
30. Controlled and modulated release of Epidermal Growth Factor10.1016/0142-9612(91)90107-L ↗
31. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 210.1074/jbc.M102628200 ↗
32. Injectable glycosaminoglycan hydrogels for controlled release of human Epidermal Growth Factor10.1016/j.biomaterials.2005.03.012 ↗
33. Critical review in oral biology & medicine: factors affecting wound healing10.1177/0022034509359125 ↗
34. Development and characterization of multifunctional electrospun ferric oxide-gelatin-glycerol nanofibrous mat for wound dressing applications10.1007/s12221-016-6915-8 ↗
35. Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faeciumharboring LiaSR substitutions10.1093/cid/ciu642 ↗
36. Editorial commentary: linezolid versus daptomycin for vancomycin-resistant enterococci: the evidence gap between trials and clinical experience10.1093/cid/civ449 ↗
37. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients10.1016/j.burns.2015.01.001 ↗
38. Sustainable antimicrobial effect of silver sulfadiazine-loaded nanosheets on infection in a mouse model of partial-thickness burn injury10.1016/j.actbio.2015.05.035 ↗
39. Sustainable antimicrobial effect of silver sulfadiazine-loaded nanosheets on infection in a mouse model of partial-thickness burn injury
40. Graphene-based materials for tissue engineering10.1016/j.addr.2016.03.007 ↗
41. Graphene-based nanomaterials for drug and/or gene delivery, bioimaging, and tissue engineering10.1016/j.drudis.2017.04.002 ↗